ArticleBone marrow transplantation2016
Similar outcome of calreticulin type I and calreticulin type II mutations following RIC allogeneic haematopoietic stem cell transplantation for myelofibrosis.
M Christopeit et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it